Identifying which specific pharmaceutical company trades at the absolute lowest nominal share price involves tracking hundreds of micro-cap, penny-stock biotechnology and drug development firms listed on global over-the-counter exchanges or major public boards. Because share prices fluctuate constantly and low-tier equities frequently undergo reverse stock splits or sharp dilutions, exact positioning changes daily. Investors generally look at market capitalization rather than absolute per-share nominal value to measure true corporate size.